PARALLEL PROFILE Trademark

Trademark Overview

On Thursday, November 9, 2017, a trademark application was filed for PARALLEL PROFILE with the United States Patent and Trademark Office. The USPTO has given the PARALLEL PROFILE trademark a serial number of 87677776. The federal status of this trademark filing is REGISTERED as of Tuesday, March 19, 2019. This trademark is owned by Parallel Testing, Inc.. The PARALLEL PROFILE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information to consumers in the form of reports, in the fields of patient safety and medication efficacy focusing on their medications, interactions with other medications, dosage, genetics and diet
parallel profile

General Information

Serial Number87677776
Word MarkPARALLEL PROFILE
Filing DateThursday, November 9, 2017
Status700 - REGISTERED
Status DateTuesday, March 19, 2019
Registration Number5704368
Registration DateTuesday, March 19, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2018

Trademark Statements

Goods and ServicesProviding medical information to consumers in the form of reports, in the fields of patient safety and medication efficacy focusing on their medications, interactions with other medications, dosage, genetics and diet
Disclaimer with Predetermined Text"PROFILE"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 20, 2017
Primary Code044
First Use Anywhere DateFriday, October 13, 2017
First Use In Commerce DateMonday, October 1, 2018

Trademark Owner History

Party NameParallel Testing, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33432
Party NameParallel Testing, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33432
Party NameParallel Testing, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33432

Trademark Events

Event DateEvent Description
Tuesday, March 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 19, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, February 12, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, February 11, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 25, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, December 24, 2018USE AMENDMENT FILED
Friday, January 25, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 24, 2018TEAS STATEMENT OF USE RECEIVED
Monday, December 24, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 22, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 5, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 5, 2018NON-FINAL ACTION E-MAILED
Thursday, April 5, 2018NON-FINAL ACTION WRITTEN
Wednesday, March 14, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 28, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 28, 2018NON-FINAL ACTION E-MAILED
Wednesday, February 28, 2018NON-FINAL ACTION WRITTEN
Thursday, February 22, 2018ASSIGNED TO EXAMINER
Monday, November 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 13, 2017NEW APPLICATION ENTERED

Related Keywords

profile parallel medications their focusing interactions other diet genetics dosage efficacy medication